UPMC Hillman Cancer Center at Butler Health System is a clinical research site located in Butler, Pennsylvania, United States 16001.
Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.
UPMC Hillman Cancer Center at Butler Health System has participated in 27 clinical trials with 25 currently active.
Therapeutic areas: Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Sponsors: SWOG Cancer Research Network, Seagen, a wholly owned subsidiary of Pfizer, National Cancer Institute (NCI).
Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
UPMC Hillman Cancer Center at Butler Health System has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC Hillman Cancer Center at Butler Health System has 27 clinical trials on record, with 25 currently active. Their work covers Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8.
Yes — UPMC Hillman Cancer Center at Butler Health System holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.